Will an Acquisition Save CannTrust (TSX:TRST)?

There have been rumours recently of CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) possibly being acquired, but investors shouldn’t get their hopes up just yet.

CannTrust Holdings (TSX:TRST)(NYSE:CTST) has come under fire in the past couple of weeks amid a scandal that could threaten the company’s ability to continue operating as a cannabis producer. With the company found to be in violation of Health Canada’s regulations, it faces the possibility of losing its licence, which could destroy any value the stock has left today. It has already lost more than 40% in value since news of the infraction was revealed.

However, recently there have been rumours circulating that the company could possibly be acquired and that a “white knight” could save CannTrust from losing its licence.

Here’s why it could happen

CannTrust has lost a lot of value in a short period of time, and under normal circumstances, that would make the stock a lot more appealing for a potential takeover, since the acquiring company could get it at a significant discount. CannTrust is one of the larger producers in the country and could instantly add a lot of value for a buyer.

According to BNN Bloomberg, there has been an effort behind the scenes to try and find a buyer for CannTrust. And there’s even been a company that’s reached out to Health Canada to see if overtaking CannTrust’s operations and helping ensure that they are compliant would be a possible solution for the regulator. It’s clear that, at a minimum, the company could stand to benefit from new management and that a producer with a better track record with Health Canada could help CannTrust clean up its act.

At its current valuation, there’s likely a lot of interest in the company. Even for CannTrust’s assets alone, there could be interest from other producers, especially when supply is a bit of premium these days.

Here’s why it might not happen

The main reason that we may not see an acquisition happen is that there’s too much uncertainty today. Without knowing where Health Canada will go with this issue and if new management would be enough to avoid the company losing its licence, it’s simply too much risk for a prospective buyer, even at CannTrust’s current valuation.

In the past, we saw a producer lose its licence, and the company did not appear to have the ability to sell or transfer it. If that’s true in CannTrust’s case, then that would certainly hurt the company’s valuation. A lack of precedents makes the current situation that much riskier for a potential buyer, especially with Health Canada being fairly quiet on the issue.

Bottom line

While there’s likely interest in the purchase of CannTrust, I wouldn’t expect a company to make an offer unless it received some assurances from Health Canada that CannTrust would be able to keep its licence. And that’s not something I’d expect the regulator to promise, certainly not at this stage.

If CannTrust continues dropping in value, then it might become worth the risk to buy the company for its assets. However, until more of a sell-off takes place, I wouldn’t expect that to happen. Currently, there’s no guarantee that a purchase of CannTrust will be enough to save the company from losing its licence, and that’s why I’d expect any prospective buyers will remain at the tire-kicking stage for now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »